GSEA analyses from TCGA prostate cancer database confirmed that patients with higher NGF levels were positively associated with gene signatures associated with upregulated neuronal developmental-responsive signaling (KEGG, Gene Ontology, and Reactome, Supplementary Fig. 1c). This evidence concerns the gene NGF and prostate carcinoma.